References
- Dever JB, Sheikh MY. Review article: spontaneous bacterial peritonitis – bacteriology, diagnosis, treatment, risk factors and prevention. Aliment Pharmacol Ther. 2015;41(11):1116–1131. doi: 10.1111/apt.13172
- Aithal GP, Palaniyappan N, China L, et al. Guidelines on the management of ascites in cirrhosis. Gut. 2021;70(1):9–29. doi: 10.1136/gutjnl-2020-321790
- Klaerner HG, Eschenbach U, Kamereck K, et al. Failure of an automated blood culture system to detect nonfermentative gram-negative bacteria. J Clin Microbiol. 2000;38(3):1036–1041. doi: 10.1128/jcm.38.3.1036-1041.2000
- Ghassemi S, Garcia-Tsao G. Prevention and treatment of infections in patients with cirrhosis. Best Pract Res Clin Gastroenterol. 2007;21(1):77–93. doi: 10.1016/j.bpg.2006.07.004
- Qiu Y, Tu GW, Ju MJ, et al. The immune system regulation in sepsis: from innate to adaptive. Curr Protein Pept Sci. 2019;20(8):799–816. doi: 10.2174/1389203720666190305164128
- Schiff DE, Rae J, Martin TR, et al. Increased phagocyte FcγRI expression and improved Fcγ-receptor–mediated phagocytosis after in vivo recombinant human interferon-γ treatment of normal human subjects. Blood. 1997;90(8):3187–3194. doi: 10.1182/blood.V90.8.3187
- Gericke GH, Ericson SG, Pan L, et al. Mature polymorphonuclear leukocytes express high-affinity receptors for IgG (FcγRI) after stimulation with granulocyte colony-stimulating factor (G-CSF). J Leukoc Biol. 1995;57(3):455–461. doi: 10.1002/jlb.57.3.455
- Davis BH. Improved diagnostic approaches to infection/sepsis detection. Expert Rev Mol Diagn. 2005;5(2):193–207. doi: 10.1586/14737159.5.2.193
- Comins-Boo A, Gutiérrez-Larrañaga M, Roa-Bautista A, et al. Validation of a quick flow cytometry-based assay for acute infection based on CD64 and CD169 expression. New tools for early diagnosis in COVID-19 pandemic. Brief research report. Front Med. 2021;8:8. doi: 10.3389/fmed.2021.655785
- Li S, Huang X, Chen Z, et al. Neutrophil CD64 expression as a biomarker in the early diagnosis of bacterial infection: a meta-analysis. Int J Infect Dis. 2013;17(1):e12-23–e23. doi: 10.1016/j.ijid.2012.07.017
- Groselj-Grenc M, Derganc M, Kopitar AN, et al. Neutrophil CD64 index in cerebrospinal fluid as a marker of bacterial ventriculitis in children with external ventricular drainage. BMC Pediatr. 2019;19(1):132. doi: 10.1186/s12887-019-1497-4
- Qin L, Wang H, Zhao C, et al. Serum and synovial biomarkers for distinguishing between chronic periprosthetic joint infections and rheumatoid arthritis: a prospective cohort study. J Arthroplasty. 2022;37(2):342–346. doi: 10.1016/j.arth.2021.09.009
- Bourgoin P, Soliveres T, Barbaresi A, et al. CD169 and CD64 could help differentiate bacterial from CoVID-19 or other viral infections in the emergency department. Cytometry A.2021;99(5):435–445. doi: 10.1002/cyto.a.24314
- Arvaniti V, D'Amico G, Fede G, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology. 2010;139(4):1246–1256. doi: 10.1053/j.gastro.2010.06.019
- Comolli G, Torchio M, Lenta E, et al. Neutrophil CD64 expression: a reliable diagnostic marker of infection in advanced cancer patients? New Microbiol. 2015;38(3):427–430.
- Liu Q, Gao Y, Ou Q, et al. Differential expression of CD64 in patients with Mycobacterium tuberculosis infection: a potential biomarker for clinical diagnosis and prognosis. J Cell Mol Med. 2020;24(23):13961–13972. doi: 10.1111/jcmm.16004